Increased risk of adverse acute myeloid leukemia after anti-CD19-targeted immunotherapies in KMT2A-rearranged acute lymphoblastic leukemia: a case report and review of the literature
2019 ◽
Vol 60
(7)
◽
pp. 1827-1830
◽
2006 ◽
Vol 81
(3)
◽
pp. 178-185
◽
2019 ◽
Vol 60
(9)
◽
pp. 2104-2114
◽
2000 ◽
Vol 65
(4)
◽
pp. 319-321
◽
Keyword(s):